Prognosis
Swiss Delay Approval of Astra’s Covid Shot to Seek More Data
- Swiss stand out in Europe in cautious stance on Astra vaccine
- Regulator says current data don’t point to positive decision
This article is for subscribers only.
Switzerland wants AstraZeneca Plc to provide more data on its Covid-19 vaccine before deciding whether to authorize the shot, taking a more cautious stance than its neighbors.
“The data currently available do not point to a positive decision regarding benefits and risks,” the country’s regulator, Swissmedic, said in a statement Wednesday.